Physician profile
Mary E Hacker
NPI 1295450120
$548.49
in general payments reported to CMS, 2019-2025
15 companies · $14.00 in 2025
The $14.00 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $261 · 2023: $260 · 2024: $13.55 · 2025: $14.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $287.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $73.14 | 2023-2025 | |
| Dexcom, INC. | $70.74 | 2022-2023 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $65.74 | 2022-2023 | Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $50.02 | 2022-2023 | |
| Lilly USA, LLC | $46.04 | 2022-2023 | Mounjaro, Trulicity |
| Amgen INC. | $35.62 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.70 | 2022-2023 | Trintellix |
| Exact Sciences Corporation | $31.99 | 2023 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.68 | 2023 | Trulance |
| Idorsia Pharmaceuticals US INC | $28.46 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $18.28 | 2022 | |
| Janssen Pharmaceuticals, INC | $18.11 | 2022 | |
| Corium, LLC | $16.33 | 2023 | Azstarys |
| Sanofi-Aventis U.S. LLC | $15.02 | 2022 | |
| Novo Nordisk INC | $14.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Hacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.